Lundbeck
HLUN-B.CO
#2582
Rank
HK$41.78 B
Marketcap
HK$43.84
Share price
-0.98%
Change (1 day)
18.19%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$18.26 Billion

According to Lundbeck 's latest financial reports the company's total liabilities are HK$18.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lundbeck - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$17.76 B-5.28%
2022-12-31HK$18.75 B-3.49%
2021-12-31HK$19.43 B-20.4%
2020-12-31HK$24.41 B-2.06%
2019-12-31HK$24.93 B137.21%
2018-12-31HK$10.51 B10.16%
2017-12-31HK$9.54 B-17.37%
2016-12-31HK$11.54 B-18.94%
2015-12-31HK$14.24 B-7.17%
2014-12-31HK$15.34 B5.1%
2013-12-31HK$14.59 B26.97%
2012-12-31HK$11.49 B9.53%
2011-12-31HK$10.49 B9.81%
2010-12-31HK$9.55 B-23.11%
2009-12-31HK$12.43 B70.85%
2008-12-31HK$7.27 B-7.23%
2007-12-31HK$7.84 B16.9%
2006-12-31HK$6.71 B32.16%
2005-12-31HK$5.07 B-2.19%
2004-12-31HK$5.19 B